Abstract
Introduction
The complement system is an essential element of the innate immune system such that the lack of complement components may cause a severe disturbance in host defense. The 4th component of complement consists of C4A and C4B isozymes, and plays an important role in the activation of the classical pathway. Although C4A deficiency is well described as a cause of systemic lupus erythematosus (SLE) (1) , there are few case reports regarding C4B deficiency. In this report we present a case of complete deficiency of C4B associated with long-term nephropathy and discuss the relationships between complement deficiency and renal disease. A 10-year- (Fig. 1-A,  Fig. 1-B) . Subendothelial deposits were confirmed on electron microscopy ( Fig. 2-A 
Case Report

L i g h t mi c r o g r a p h o f t h e r e n a l b i o p s i e s ( × 6 0 ) . ( A) P AS a n d ( B ) P AM s t a i n o f t h e s e c o n d b i o p s y . Do u b l e c o n t o u r s o f t h e b a s e me n t me mb r a n e ( a r r o ws ) a n d p a r a me s a n g i a l d e p o s i t s ( a r r o w h e a d ) a r e s e e n . ( C) P AS a n d ( D) P AM s t a i n o f t h e t h i r d b i o p s y .
Me s a n g i a l p r o l i f e r a t i o n a n d c a p i l l a r y wa l l t h i c k e n i n g o f t h e g l o me r u l a r b a s e me n t me mb r a n e a r e o b s e r v e d . ( E ) P AS a n d ( F ) P AM s t a i n o f t h e f o u r t h r e n a l b i o p s y . Ne w c r e s c e n t f o r ma t i o n i s e v i d e n t . (Fig. 1-C, Fig. 1-D) .
Electron microscopy revealed dense deposits in the paramesangial area ( Fig. 2-B ) and myxo-virus-like particles in the endothelial cells (Fig. 2-C (Fig. 1-E,  Fig. 1-F) . Electron micrographs showed mesangial interposition (Fig. 2-D) . Immunofluorescent staining was positive for immunoglobulin and C3 but still negative for C4 (Fig. 3) . A diagnosis of crescentic glomerulonephritis was made and she received methylprednisolone pulse therapy (0.5 g per day) followed by oral corticosteroid therapy.
F i g u r e 2 . E l e c t r o n mi c r o g r a p h s o f t h e r e n a l b i o p s i e s . ( A) I n t h e s e c o n d b i o p s y , s u b e p i t h e l i a l d ep o s i t s a r e s e e n ( a r r o wh e a d ) . I n t h e t h i r d b i o p s y ( B , C) , d e n s e d e p o s i t s i n t h e p a r a me s a n g i a l a r e a ( s t a r ) a n d my x o -v i r u s l i k e p a r t i c l e ( a r r o wh e a d ) a r e o b s e r v e d . ( D) I n t h e f o u r t h b i o p s y , me s a n g i a l i n t e r p o s i t i o n i s e v i d e n t ( a s t e r i s k ) .
T a b l e 1 . L a b o r a t o r y F i n d i n g s J u s t b e f o r e t h e F o u r t h Re n a l B i o p s y
The urinary findings responded to corticosteroid therapy but the low serum level of C4 persisted (Fig. 4) . We suspected an underlying complement deficiency and therefore performed gene analysis and allotyping according to previously reported methods (2, 3) .
Polymerase chain reaction (PCR) amplification of C4A and C4B genes was based on the method of Barba et al (4) . Genomic DNA was extracted from peripheral blood leukocytes after informed consent was obtained from the patient. Three sets of isotype-specific primers were prepared according to previously described sequences (2) . A set of primers (C4AI) for the C4A gene, and two sets of primers (C4BI (Fig. 6 ).
F i g u r e 3 . Mi c r o g r a p h o f i mmu n o f l u o r e s c e n t s t a i n i n g o f g l o me r u l i o f t h e f o u r t h r e n a l b i o p s y ( × 6 0 ) . ( A) I g M s t a i n ( B ) I g A s t a i n ( C) C3 s t a i n ( D) C4 s t a i n . On l y s t a i n i n g f o r C4 i s n e g a t i v e .
GGT CCC CTG GGC CT -3´(C4BII set). PCR amplification was performed according to the protocol of X-Y Man et al (2). The PCR products, including C4AI (377bp), C4BI (377bp) and C4BII (578bp) were then applied on a 5% polyacrylamide gel and stained with ethidium bromide. The samples of this patient could not be amplified by primers for isotypes of C4B (Fig. 5). The western blotting assay to reveal the haplotypes of C4 was performed according to the method of Sim and Cross (3). Samples of plasma (7.5 μl) were treated with 1 μl of carboxypeptidase B (type I) and 1 μl of neuraminidase (type VI) and incubated at 4 overnight. A 0.8% Seakem agarose gel was made with tris-glycine-veronal buffer at pH 8.0 and electrophoresis was carried out under the following conditions: 30 minutes at 300V, 30 minutes at 400V, three hours at 500V and 30 minutes at 600V. The gel was then exposed to rabbit anti-human C4 antibodies (Dako, High Wycombe, Bucks, U.K.) and immersed in saline overnight in order to eliminate excessive protein and antibodies. Finally, the gel was dried on a gel bond film and was stained with Coomasie Brilliant Blue R250. The haplotypes of this patient were C4A3, BQ0/C4A3, 2 BQ0 thereby confirming a diagnosis of complete C4B deficiency
Discussion
In this case, the patient underwent a renal biopsy on 4 occasions and we obtained findings suspicious of lupus nephritis each time. However, she had no symptoms of arthritis, stomatitis or skin rash typical of lupus such that her symptoms and serological profile never satisfied the classification criteria for SLE (5) . In addition, she exhibited a low C4 level during the extended period of observation. Finally, the genetic phenotyping of complement revealed that she was homozygous for C4B deficiency.
The 4th component of complement belongs to the classi-
F i g u r e 5 . S p e c i f i c P CR a n a l y s i s o f C4 AI wi t h p r i me r s Au p / L 3 ( A) , C4 B I wi t h p r i me r s B u p / L 3 ( B ) a n d C4 B I I wi t h p r i me r s B d o / L 4 ( C) . L a n e 1 i s t h e DNA s i z e ma r k e r ( B i o L a b s , 1 0 0 b p DNA l a d d e r N3 2 3 1 L ) . T h e a r r o ws i n d i c a t e 4 0 0 b p s b a n d s ( A, B ) . T h e a r r o wh e a d i n d i c a t e s 5 0 0 b p s b a n d ( C) . L a n e s 2 a n d 3 a r e s a mp l e s o f o t h e r S L E p a t i e n t s . L a n e 4 i s a s a mp l e o f t h i s c a s e . No b a n d s o f
C4 B a r e s e e n i n l a n e 4 .
F i g u r e 6 . T y p i n g o f C4 b y we s t e r n b l o t t i n g ( Ag a r o s e s l a b g e l e l e c t r o p h o r e s i s a n d i mmu n o s t a i n i n g
) . L a n e 1 a n d 8 : t h e s a mp l e o f t h i s c a s e . L a n e 2 : A5 , 3 , B 2 , 2 . L a n e 3 : A3 , 3 B 5 , 2 . L a n e 4 : A3 , 3 B 1 , 1 . L a n e 5 : A3 , 3 , 2 B 1 , Q0 . L a n e 6 : A3 , 3 B 1 , 1 L a n e 7 : A4 , 3 B 5 , 2 I n l a n e s 1 a n d (6) . In contrast, C4B is 10 times more reactive than C4A with targets containing hydroxyl groups (6) 
, t h e A3 b a n d i s d e n s e r t h a n t h e A2 o n e , b u t n o B -l o c i b a n d s a r e s e e n . T h i s r e s u l t i s i n t e r p r e t e d a s d u p l i c a t i o n o f C4 A3 a n d d e p l e t i o n o f C4 B ( C4 B Q0 ) . T h u s , t h e h a p l o t y p e s o f t h i s c a s e a r e C4 A3
. Activated C4B results in transesterification of the target and this is important for the propagation of the classical and the mannose-binding lectin pathway of complement activation. This reaction finally leads to formation of the critically important membrane attack complex against microbes (7).
C4B deficiency is considered to be involved in various diseases (9) including severe infections (10) . Although several reports have mentioned renal diseases associated with C 4B deficiency (11, 12) (16, 17) , we believe that it is necessary to consider complement deficiency in the differential diagnosis of microscopic hematuria.
